Epigenetic regulation of oxysterol formation

Biochimie

Volumn 95, Issue 3, 2013, Pages 531-537

  Meaney, Steve ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

24 hydroxycholesterol 7 hydroxylase; CH25H; Cholesterol; Cholesterol 24 hydroxylase; Cholesterol 25 hydroxylase; Cholesterol 7 hydroxylase; CYP27A1; CYP39A1; CYP3A4; CYP46A1; CYP7B1; Epigenetics; Epigenomics; Oxysterol; Oxysterol 7 hydroxylase; Sterol 27 hydroxylase

Indexed keywords

OXYSTEROL;

CH25H GENE; CHOLESTANETRIOL 26 MONOOXYGENASE GENE; CHOLESTEROL 7ALPHA MONOOXYGENASE GENE; CYP39A1 GENE; CYP46A1 GENE; CYP7B1 GENE; CYTOCHROME P450 3A4 GENE; EPIGENETICS; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; REVIEW;

ANIMALS; CHOLESTEROL; EPIGENESIS, GENETIC; HUMANS; STEROID HYDROXYLASES;

EID: 84874115315     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.08.020     Document Type: Review

References (60)

1. L. Iuliano Pathways of cholesterol oxidation via non-enzymatic mechanisms Chem. Phys. Lipids 164 2011 457 468
2. M. Norlin, and K. Wikvall Enzymes in the conversion of cholesterol into bile acids Curr. Mol. Med. 7 2007 199 218
3. D.W. Russell Oxysterol biosynthetic enzymes Biochim. Biophys. Acta 1529 2000 126 135
4. W.J. Griffiths, and Y. Wang Analysis of oxysterol metabolomes Biochim. Biophys. Acta 1811 2011 784 799
5. C. Xie, E.G. Lund, S.D. Turley, D.W. Russell, and J.M. Dietschy Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration J. Lipid Res. 44 2003 1780 1789
6. D.W. Russell, R.W. Halford, D.M. Ramirez, R. Shah, and T. Kotti Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain Annu. Rev. Biochem. 78 2009 1017 1040
7. J.Y. Chiang Bile acids: regulation of synthesis J. Lipid Res. 50 2009 1955 1966
8. A.C. Calkin, and P. Tontonoz Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR Nat. Rev. Mol. Cell. Biol. 13 2012 213 224
9. B.M. Turner The adjustable nucleosome: an epigenetic signaling module Trends Genet. 2012
10. I. Tirosh, and N. Barkai Two strategies for gene regulation by promoter nucleosomes Genome Res. 18 2008 1084 1091
11. S.L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard An operational definition of epigenetics Genes Dev. 23 2009 781 783
12. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2010 27 36
13. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
14. P.A. Jones Functions of DNA methylation: islands, start sites, gene bodies and beyond Nat. Rev. Genet. 13 2012 484 492
15. A. Flaus, and T. Owen-Hughes Mechanisms for ATP-dependent chromatin remodelling: the means to the end FEBS J. 278 2012 3579 3595
16. J.K. Kemper, H. Kim, J. Miao, S. Bhalla, and Y. Bae Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP Mol. Cell. Biol. 24 2004 7707 7719
17. Z. Smith, D. Ryerson, and J.K. Kemper Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors Mol. Cell. Endocrinol. 2012
18. Y. Zhang, C.H. Hagedorn, and L. Wang Role of nuclear receptor SHP in metabolism and cancer Biochim. Biophys. Acta 1812 2012 893 908
19. S. Fang, S. Tsang, R. Jones, B. Ponugoti, H. Yoon, S.Y. Wu, C.M. Chiang, T.M. Willson, and J.K. Kemper The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP J. Biol. Chem. 283 2008 35086 35095
20. D.H. Kim, J. Lee, B. Lee, and J.W. Lee ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity Mol. Endocrinol. 23 2009 1556 1562
21. S.K. Knutson, B.J. Chyla, J.M. Amann, S. Bhaskara, S.S. Huppert, and S.W. Hiebert Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks EMBO J. 27 2008 1017 1028
22. J. Gobinet, S. Carascossa, V. Cavailles, F. Vignon, J.C. Nicolas, and S. Jalaguier SHP represses transcriptional activity via recruitment of histone deacetylases Biochemistry 44 2005 6312 6320
23. T. Li, J.M. Francl, S. Boehme, A. Ochoa, Y. Zhang, C.D. Klaassen, S.K. Erickson, and J.Y. Chiang Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity J. Biol. Chem. 287 2012 1861 1873
24. N. Mitro, C. Godio, E. De Fabiani, E. Scotti, A. Galmozzi, F. Gilardi, D. Caruso, A.B. Vigil Chacon, and M. Crestani Insights in the regulation of cholesterol 7α-hydroxylase gene reveal a target for modulating bile acid synthesis Hepatology 46 2007 885 897
25. A. Babiker, O. Andersson, E. Lund, R.J. Xiu, S. Deeb, A. Reshef, E. Leitersdorf, U. Diczfalusy, and I. Bjorkhem Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport J. Biol. Chem. 272 1997 26253 26261
26. A.B. Reiss, K.O. Martin, N.B. Javitt, D.W. Martin, E.A. Grossi, and A.C. Galloway Sterol 27-hydroxylase: high levels of activity in vascular endothelium J. Lipid Res. 35 1994 1026 1030
27. I.A. Pikuleva, A. Babiker, M.R. Waterman, and I. Bjorkhem Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways J. Biol. Chem. 273 1998 18153 18160
28. G. Escher, A. Hoang, S. Georges, U. Tchoua, A. El-Osta, Z. Krozowski, and D. Sviridov Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages J. Lipid Res. 46 2005 356 365
29. S.V. Chittur, N. Sangster-Guity, and P.J. McCormick Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism BMC Genomics 9 2008 507
30. M. Shafaati, R. O'Driscoll, I. Bjorkhem, and S. Meaney Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors Biochem. Biophys. Res. Commun. 378 2009 689 694
31. Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, E. Feinstein, and I. Bjorkhem Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes J. Biol. Chem. 281 2006 3810 3820
32. N. Ballas, C. Grunseich, D.D. Lu, J.C. Speh, and G. Mandel REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis Cell 121 2005 645 657
33. I. Milagre, M.J. Nunes, M. Moutinho, I. Rivera, A. Fuso, S. Scarpa, M.J. Gama, and E. Rodrigues Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination J. Alzheimers Dis. 22 2010 1209 1221
34. M.J. Nunes, I. Milagre, M. Schnekenburger, M.J. Gama, M. Diederich, and E. Rodrigues Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription J. Neurochem. 113 2010 418 431
35. M.J. Nunes, M. Moutinho, I. Milagre, M.J. Gama, and E. Rodrigues Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway J. Lipid Res. 53 2012 1910 1919
36. R. Lu, J. Ito, N. Iwamoto, T. Nishimaki-Mogami, and S. Yokoyama FGF-1 induces expression of LXRalpha and production of 25-hydroxycholesterol to upregulate the apoE gene in rat astrocytes J. Lipid Res. 50 2009 1156 1164
37. P.Y. Wang, J. Weng, and R.G. Anderson OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation Science 307 2005 1472 1476
38. I. Milagre, M. Olin, M.J. Nunes, M. Moutinho, A. Lovgren-Sandblom, M.J. Gama, I. Bjorkhem, and E. Rodrigues Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells Neurochem. Int. 60 2012 192 198
39. N. Ballas, and G. Mandel The many faces of REST oversee epigenetic programming of neuronal genes Curr. Opin. Neurobiol. 15 2005 500 506
40. J.E. Phillips, and V.G. Corces CTCF: master weaver of the genome Cell 137 2009 1194 1211
41. U. Diczfalusy, K.E. Olofsson, A.M. Carlsson, M. Gong, D.T. Golenbock, O. Rooyackers, U. Flaring, and H. Bjorkbacka Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide J. Lipid Res. 50 2009 2258 2264
42. K. Park, and A.L. Scott Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons J. Leukoc. Biol. 88 2010 1081 1087
43. L. Klampfer, J. Huang, L.A. Swaby, and L. Augenlicht Requirement of histone deacetylase activity for signaling by STAT1 J. Biol. Chem. 279 2004 30358 30368
44. E.S. Gold, S.A. Ramsey, M.J. Sartain, J. Selinummi, I. Podolsky, D.J. Rodriguez, R.L. Moritz, and A. Aderem ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation J. Exp. Med. 209 2012 807 817
45. K. Bodin, L. Bretillon, Y. Aden, L. Bertilsson, U. Broome, C. Einarsson, and U. Diczfalusy Antiepileptic drugs increase plasma levels of 4β-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4 J. Biol. Chem. 276 2001 38685 38689
46. A. Honda, T. Miyazaki, T. Ikegami, J. Iwamoto, T. Maeda, T. Hirayama, Y. Saito, T. Teramoto, and Y. Matsuzaki Cholesterol 25-hydroxylation activity of CYP3A J. Lipid Res. 52 2011 1509 1516
47. M.R. Ahn, D.K. Kim, and Y.Y. Sheen Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells Arch. Pharm. Res. 27 2004 415 421
48. J.Y. Kim, M.R. Ahn, D.K. Kim, and Y.Y. Sheen Histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in HepG2 cells Arch. Pharm. Res. 27 2004 407 414
49. Y. Xie, S. Ke, N. Ouyang, J. He, W. Xie, M.T. Bedford, and Y. Tian Epigenetic regulation of transcriptional activity of Pregnane X receptor by protein arginine methyltransferase 1 J. Biol. Chem. 284 2009 9199 9205
50. W. Habano, T. Gamo, J. Terashima, T. Sugai, K. Otsuka, G. Wakabayashi, and S. Ozawa Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells BMC Cancer 11 2011 81
51. N. Leuenberger, S. Pradervand, and W. Wahli Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice J. Clin. Invest. 119 2009 3138 3148
52. M. Olsson, O. Gustafsson, C. Skogastierna, A. Tolf, B.D. Rietz, R. Morfin, A. Rane, and L. Ekstrom Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma Prostate 67 2007 1439 1446
53. J. Li-Hawkins, E.G. Lund, A.D. Bronson, and D.W. Russell Expression cloning of an oxysterol 7α-hydroxylase selective for 24-hydroxycholesterol J. Biol. Chem. 275 2000 16543 16549
54. H. Ikeda, M. Ueda, M. Ikeda, H. Kobayashi, and Y. Honda Oxysterol 7α-hydroxylase (CYP39A1) in the ciliary nonpigmented epithelium of bovine eye Lab. Invest. 83 2003 349 355
55. W. Zheng, R.E. Reem, S. Omarova, S. Huang, P.L. DiPatre, C.D. Charvet, C.A. Curcio, and I.A. Pikuleva Spatial distribution of the pathways of cholesterol homeostasis in human retina PLoS One 7 2010 e37926
56. S. Steckelbroeck, M. Watzka, D. Lutjohann, P. Makiola, A. Nassen, V.H. Hans, H. Clusmann, A. Reissinger, M. Ludwig, L. Siekmann, and D. Klingmuller Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7α-hydroxylase and 17-ketosteroid reductase activity in the human brain J. Neurochem. 83 2002 713 726
57. M. Oscarson, U.M. Zanger, O.F. Rifki, K. Klein, M. Eichelbaum, and U.A. Meyer Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine Clin. Pharmacol. Ther. 80 2006 440 456
58. N.M. Teplyuk, Y. Zhang, Y. Lou, J.R. Hawse, M.Q. Hassan, V.I. Teplyuk, J. Pratap, M. Galindo, J.L. Stein, G.S. Stein, J.B. Lian, and A.J. van Wijnen The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts Mol. Endocrinol. 23 2009 849 861
59. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, L. Conti, T. Cataudella, B.R. Leavitt, M.R. Hayden, T. Timmusk, D. Rigamonti, and E. Cattaneo Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat. Genet. 35 2003 76 83
60. M. Valenza, V. Leoni, J.M. Karasinska, L. Petricca, J. Fan, J. Carroll, M.A. Pouladi, E. Fossale, H.P. Nguyen, O. Riess, M. MacDonald, C. Wellington, S. DiDonato, M. Hayden, and E. Cattaneo Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes J. Neurosci. 30 2010 10844 10850